Literature DB >> 2242083

Antioxidant activity of and interleukin production affected by honey bee venom.

E Rekka1, L Kourounakis, P Kourounakis.   

Abstract

Honey bee venom is found to inhibit significantly nonenzymatic lipid peroxidation. It also possesses a considerable hydroxyl radical scavenging activity, evaluated by its competition with dimethyl sulfoxide for HO.. These results, in relation to the in vitro suppression mainly of interleukin-1 production offered by honey bee venom, may further support that antioxidant activity is involved in the anti-inflammatory activity of honey bee venom.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242083

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  alpha1-Acid glycoprotein production in rat dorsal air pouch in response to inflammatory stimuli, dexamethasone and honey bee venom.

Authors:  K Vasileiadou; G Pantazidis; K Papadopoulou; C Ligoudistianou; A Kourelis; S Petrakis; E Masmanidou; T Testa; A P Kourounakis; L Hadjipetrou; J Papaconstantinou; M Yiangou
Journal:  Exp Mol Pathol       Date:  2010-04-02       Impact factor: 3.362

2.  Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development.

Authors:  M Yiangou; C Konidaris; P Victoratos; L Hadjipetrou-Kourounakis
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

Review 3.  Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.

Authors:  Juliana Silva; Victoria Monge-Fuentes; Flávia Gomes; Kamila Lopes; Lilian dos Anjos; Gabriel Campos; Claudia Arenas; Andréia Biolchi; Jacqueline Gonçalves; Priscilla Galante; Leandro Campos; Márcia Mortari
Journal:  Toxins (Basel)       Date:  2015-08-18       Impact factor: 4.546

4.  Role of Bee Venom and Melittin on Restraining Angiogenesis and Metastasis in γ-Irradiated Solid Ehrlich Carcinoma-Bearing Mice.

Authors:  Nermeen M El Bakary; Asmaa Z Alsharkawy; Zeinab A Shouaib; Emad M S Barakat
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.